STAT3 and autoimmune disease: STAT3 phosphorylation and IL-6 signaling are known to interfere with the delicate balance between Treg and Teff cells [21], [22], a phenomenon often observed in autoimmune disease [22], [49], [50], supporting the pro-inflammatory potential of TL1A.